Clinical Trials Browser

Phase 2 × ADI PEG20 × Other hematologic neoplasm × Clear all

NCT01910012 2020-10-01

PH 2 ADI-PEG 20 Acute Myeloid Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute